Tactile Medical Appoints Laura King to Board of Directors
Rhea-AI Summary
Tactile Medical (Nasdaq: TCMD) has appointed Laura King to its Board of Directors and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. Laura King brings extensive experience from her 22-year career at General Electric Company (GE), where she served as President & CEO of GE Healthcare’s Global Interventional Business. Her leadership included roles as Chief Information Officer & Chief Financial Officer for GE's Consumer & ECM Motors segment.
Currently, Ms. King is the co-founder & CEO of BiaCure, Inc., and has previously co-founded Elucent Medical, positively impacting over 10,000 breast cancer patients. She also served as President & CEO of NeuWave Medical, which was acquired by Johnson & Johnson’s MedTech division. Bill Burke, Chairman of the Board of Tactile Medical, expressed enthusiasm for Ms. King's appointment, citing her experience in leading healthcare companies and developing innovative technologies as valuable assets for the company.
Tactile Medical specializes in developing and marketing at-home therapies for chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, aiming to improve patient care and reduce healthcare costs.
Positive
- Appointment of Laura King, a seasoned healthcare executive with extensive leadership experience, to the Board of Directors.
- Ms. King's background includes high-level roles at GE Healthcare and successful entrepreneurial ventures in medical technology.
- Her appointment is expected to enhance Tactile Medical's strategic direction and innovation in at-home therapies.
Negative
- Potential concerns about continuity and the integration of new leadership into existing company culture.
News Market Reaction 1 Alert
On the day this news was published, TCMD declined 0.17%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company’s Board of Directors (“Board”) and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025.
Ms. King is a seasoned healthcare executive with a proven track record of leadership and developing innovative products that enhance patient care. Her extensive experience includes a 22-year career at General Electric Company (GE), where she served as a Company Officer in her role as President & CEO of GE Healthcare’s Global Interventional Business, which provided clinical solutions enabling minimally invasive procedures in cardiology, interventional radiology, and surgery. Her earlier experience at GE included various senior level audit and finance roles, including Chief Information Officer & Chief Financial Officer, Consumer & ECM Motors. Ms. King is currently co-founder & CEO of BiaCure, Inc., a developer of effective treatments for nail fungus. Previously, she co-founded and served as CEO of Elucent Medical, a developer of a real-time surgical navigation platform that has positively impacted over 10,000 breast cancer patients. Ms. King also served as President & CEO of NeuWave Medical, a manufacturer and marketer of a minimally invasive soft tissue microwave ablation system to destroy tumor cells, which was acquired by Johnson & Johnson’s MedTech division.
“We are thrilled to have Laura join our Board of Directors,” said Bill Burke, Chairman of the Board of Tactile Medical. “Tactile will benefit from her considerable experience leading healthcare companies that develop innovative technologies to improve patient care as we continue to expand our impact in lymphedema, airway clearance, and other at-home therapies for people with underserved, chronic conditions.”
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
What is the significance of Laura King's appointment to TCMD's Board of Directors?
When did Laura King join the Board of Directors at TCMD?
What roles will Laura King serve on TCMD's Board?
How might Laura King's experience benefit TCMD?
What previous roles has Laura King held?
What impact could Laura King's leadership have on TCMD's stock performance?
